{"id":72691,"date":"2023-08-31T13:03:01","date_gmt":"2023-08-31T11:03:01","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&p=72691"},"modified":"2026-02-17T16:41:42","modified_gmt":"2026-02-17T15:41:42","slug":"veeva-clinical-database-crosses-200-study-milestone-cuts-time-to-aggregate-and-clean-study-data-by-30-50","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-clinical-database-crosses-200-study-milestone-cuts-time-to-aggregate-and-clean-study-data-by-30-50\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ Clinical Database Crosses 200 Study Milestone, Cuts Time to Aggregate and Clean Study Data by 30-50%"},"content":{"rendered":"

Next-generation clinical data application harmonizes data for efficiency and speed<\/em><\/p>\n

BARCELONA, Spain \u2014 31 Aug. 2023<\/strong> \u2014 ³Ô¹Ï±¬ÁÏ Clinical Database (CDB)<\/a> enables innovative ways of managing clinical trial data, saving customers 30 to 50% of the time required to aggregate, clean, and transform data. Since ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) announced its launch, ³Ô¹Ï±¬ÁÏ CDB has cleaned more than 200,000 subjects to quickly provide quality data across more than 200 studies.<\/p>\n

\u201cBy launching ³Ô¹Ï±¬ÁÏ CDB and building processes around it, we\u2019re laying a foundation for clinical data transformation,\u201d said Jerry Yarem, vice president, data management, Fortrea. \u201cThis is a significant advancement that can bring together all of our data sources and deliver clean data faster than ever so study teams can make data-driven decisions with confidence.\u201d<\/p>\n

³Ô¹Ï±¬ÁÏ CDB automates processes for a new way of cleaning data that increases productivity and efficiency. Using ³Ô¹Ï±¬ÁÏ CDB Auto Checks, customers can automatically identify discrepancies upon data ingestion and create queries or close them when issues are corrected. The application also automates change detection so data managers can focus efforts on new or updated data, saving time and lowering costs.<\/p>\n

\u201c³Ô¹Ï±¬ÁÏ CDB makes collaboration with study partners and data providers easy, simplifying data transfer and configuration,\u201d said Tonya Arthur, head of data management, Acelyrin. \u201cPairing ³Ô¹Ï±¬ÁÏ\u2019s clinical data management platform and our CRO partner\u2019s expertise will improve our trial processes and provide the visibility to make informed decisions that can positively impact trial outcomes.\u201d<\/p>\n

Sponsors and contract research organizations (CROs) use ³Ô¹Ï±¬ÁÏ CDB to ingest and clean clinical data from a variety of system sources, including EDC systems such as ³Ô¹Ï±¬ÁÏ EDC<\/a> and Medidata Rave™, ePRO, and lab data. This allows sponsors to standardize and optimize processes for effective data management across systems. In addition, the ³Ô¹Ï±¬ÁÏ CDB Data Provider Program<\/a> enables qualified partners with resources to gain operational efficiencies when delivering data for ³Ô¹Ï±¬ÁÏ CDB customers.<\/p>\n

\u201cData transfers to and from ³Ô¹Ï±¬ÁÏ enable an integrated service offering that streamlines data delivery for our joint customers using ³Ô¹Ï±¬ÁÏ CDB and Clinical Ink\u2019s comprehensive suite of eCOA, direct data capture, patient engagement, and digital biomarker technologies,\u201d said Son Ly, vice president, data services, Clinical Ink.<\/p>\n

\u201cAs clinical data sources continue to grow and trial complexity increases, data managers need agile technologies to streamline the path toward clean data and insights,\u201d said Pavel Burmenko, general manager, ³Ô¹Ï±¬ÁÏ CDB. \u201cWith more than 30 data providers supplying study data, ³Ô¹Ï±¬ÁÏ CDB is gaining momentum, advancing clinical data management for seamless information exchange and faster access to high-quality data.\u201d<\/p>\n

³Ô¹Ï±¬ÁÏ CDB is part of ³Ô¹Ï±¬ÁÏ Clinical Data Management<\/a>, a modern cloud application suite combining EDC, coding<\/a>, data cleaning<\/a>, reporting<\/a>, randomization<\/a>, and trial supply management<\/a>.<\/p>\n

Additional Information<\/strong>
\nFor more on ³Ô¹Ï±¬ÁÏ CDB, visit: veeva.com\/eu\/³Ô¹Ï±¬ÁÏCDB<\/a>
\nFor more on ³Ô¹Ï±¬ÁÏ CDB Data Provider Program, visit: veeva.com\/CDBdataprovider<\/a>
\nConnect with ³Ô¹Ï±¬ÁÏ on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>\n<\/p>\n

About ³Ô¹Ï±¬ÁÏ Systems<\/strong>
\n³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n

³Ô¹Ï±¬ÁÏ Forward-looking Statements<\/strong>
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2023, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n

###<\/p>\n

\nContact:<\/strong>
\t
\nJeremy Whittaker
\n³Ô¹Ï±¬ÁÏ Systems
\n+49-695-095-5486
\njeremy.whittaker@veeva.com<\/a><\/p>\n

\nContact:<\/strong>
\t
\nDeivis Mercado
\n³Ô¹Ï±¬ÁÏ Systems
\n925-226-8821
\ndeivis.mercado@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Next-generation clinical data application harmonizes data for efficiency and speed.<\/p>\n","protected":false},"featured_media":72828,"parent":0,"template":"","class_list":["post-72691","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-clinical-data-management","resource-area-20-vault-platform-area","resource-product-20-dqs","resource-product-20-edc","resource-product-20-vault-platform","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/72691"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/72691\/revisions"}],"predecessor-version":[{"id":72831,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/72691\/revisions\/72831"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/72828"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=72691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}